27 results on '"Adamiak M"'
Search Results
2. Myeloablative Conditioning for Transplantation Induces State of Sterile Inflammation in the Bone Marrow: Implications for Optimizing Homing and Engraftment of Hematopoietic Stem Cells.
- Author
-
Ratajczak MZ, Adamiak M, Deptała A, Domagała-Kulawik J, Ratajczak J, and Kucia M
- Subjects
- Bone Marrow, Hematopoietic Stem Cells
- Abstract
Significance: The success rate of hematopoietic stem cell transplantation depends mainly on the number of transplanted hematopoietic stem/progenitor cells (HSPCs) followed by the speed of their engraftment in the myeloablated transplant recipient. Therefore, clinical outcomes will significantly benefit from accelerating the homing and engraftment of these cells. This is, in particular, important when the number of cells available for the transplantation of HSPCs is limited. Recent Advances: We postulated that myeloablative conditioning for hematopoietic transplantation by radio- or chemotherapy induces a state of sterile inflammation in transplant recipient peripheral blood (PB) and bone marrow (BM). This state is mediated by activation of the BM stromal and innate immunity cells that survive myeloablative conditioning and respond to danger-associated molecular patterns released from the cells damaged by myeloablative conditioning. As a result of this, several factors are released that promote proper navigation of HSPCs infused into PB of transplant recipient and prime recipient BM to receive transplanted cells. Critical Issues: We will present data that cellular innate immunity arm and soluble arm comprised complement cascade proteins, promoting the induction of the BM sterile inflammation state that facilitates the navigation, homing, and engraftment of HSPCs. Future Directions: Deciphering these mechanisms would allow us to better understand the mechanisms that govern hematopoietic recovery after transplantation and, in parallel, provide important information on how to optimize this process in the clinic by employing small molecular modifiers of innate immunity and purinergic signaling. Antioxid. Redox Signal. 37, 1254-1265.
- Published
- 2022
- Full Text
- View/download PDF
3. Novel Evidence That Alternative Pathway of Complement Cascade Activation is Required for Optimal Homing and Engraftment of Hematopoietic Stem/progenitor Cells.
- Author
-
Adamiak M, Ciechanowicz A, Chumak V, Bujko K, Ratajczak J, Brzezniakiewicz-Janus K, Kucia M, and Ratajczak MZ
- Subjects
- Animals, Bone Marrow metabolism, Complement Activation, Inflammasomes metabolism, Mice, Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cells
- Abstract
We reported in the past that activation of the third (C3) and fifth element (C5) of complement cascade (ComC) is required for a proper homing and engraftment of transplanted hematopoietic stem/progenitor cells (HSPCs). Since myeloablative conditioning for transplantation triggers in recipient bone marrow (BM) state of sterile inflammation, we have become interested in the role of complement in this process and the potential involvement of alternative pathway of ComC activation. We noticed that factor B deficient mice (FB-KO) that do not activate properly alternative pathway, engraft poorly with BM cells from normal wild type (WT) mice. We observed defects both in homing and engraftment of transplanted HSPCs. To shed more light on these phenomena, we found that myeloablative lethal irradiation conditioning for transplantation activates purinergic signaling, ComC, and Nlrp3 inflammasome in WT mice, which is significantly impaired in FB-KO animals. Our proteomics analysis revealed that conditioned for transplantation lethally irradiated FB-KO compared to normal control animals have lower expression of several proteins involved in positive regulation of cell migration, trans-endothelial migration, immune system, cellular signaling protein, and metabolic pathways. Overall, our recent study further supports the role of innate immunity in homing and engraftment of HSPCs., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
4. The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing-a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking.
- Author
-
Adamiak M, Bujko K, Thapa A, Pensato V, Brzezniakiewicz-Janus K, Ratajczak J, Davies DL, Ulrich H, Kucia M, and Ratajczak MZ
- Subjects
- Animals, Chemotaxis, Female, Granulocyte Colony-Stimulating Factor metabolism, Hematopoietic Stem Cells cytology, Humans, Mice, Mice, Inbred C57BL, Mice, Knockout, Receptors, Purinergic P2X7 genetics, Signal Transduction, Hematopoietic Stem Cell Mobilization methods, Hematopoietic Stem Cell Transplantation methods, Hematopoietic Stem Cells physiology, Receptors, Purinergic P2X4 physiology, Receptors, Purinergic P2X7 metabolism, Stem Cell Niche
- Abstract
Recent evidence indicates that extracellular adenosine triphosphate (eATP), as a major mediator of purinergic signaling, plays an important role in regulating the mobilization and homing of hematopoietic stem progenitor cells (HSPCs). In our previous work we demonstrated that eATP activates the P2X7 ion channel receptor in HSPCs and that its deficiency impairs stem cell trafficking. To learn more about the role of the P2X purinergic receptor family in hematopoiesis, we phenotyped murine and human HSPCs with respect to the seven P2X receptors and observed that, these cells also highly express P2X4 receptors, which shows ~50% sequence similarity to P2X7 subtypes, but that P2X4 cells are more sensitive to eATP and signal much more rapidly. Using the selective P2X4 receptor antagonist PSB12054 as well as P2X4-KO mice, we found that the P2X4 receptor, similar to P2X7 receptor, promotes trafficking of HSPCs in that its deficiency leads to impaired chemotaxis of HSPCs in response to a stromal-derived factor 1 (SDF-1) gradient, less effective pharmacological mobilization, and defective homing and engraftment of HSPCs after transplantation into myeloablated hosts. This correlated with a decrease in SDF-1 expression in the BM microenvironment. Overall, our results confirm the proposed cooperative dependence of both receptors in response to eATP signaling. In G-CSF-induced mobilization, a lack of one receptor is not compensated by the presence of the other one, which supports their mutual dependence in regulating HSPC trafficking., (© 2021. The Author(s), under exclusive licence to Springer Nature Limited.)
- Published
- 2022
- Full Text
- View/download PDF
5. An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner.
- Author
-
Kucia M, Ratajczak J, Bujko K, Adamiak M, Ciechanowicz A, Chumak V, Brzezniakiewicz-Janus K, and Ratajczak MZ
- Subjects
- Angiotensin-Converting Enzyme 2 genetics, Endothelial Progenitor Cells immunology, Endothelial Progenitor Cells metabolism, Hematopoietic Stem Cells immunology, Hematopoietic Stem Cells metabolism, Humans, Spike Glycoprotein, Coronavirus genetics, Angiotensin-Converting Enzyme 2 metabolism, Endothelial Progenitor Cells pathology, Hematopoietic Stem Cells pathology, Inflammasomes immunology, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, Pyroptosis, Spike Glycoprotein, Coronavirus metabolism
- Published
- 2021
- Full Text
- View/download PDF
6. Danger-associated molecular pattern molecules take unexpectedly a central stage in Nlrp3 inflammasome-caspase-1-mediated trafficking of hematopoietic stem/progenitor cells.
- Author
-
Thapa A, Adamiak M, Bujko K, Ratajczak J, Abdel-Latif AK, Kucia M, and Ratajczak MZ
- Subjects
- Animals, Cell Movement, Female, Granulocyte Colony-Stimulating Factor metabolism, Hematopoietic Stem Cell Transplantation methods, Inflammasomes metabolism, Inflammation metabolism, Inflammation therapy, Interleukin-1beta metabolism, Mice, Mice, Inbred C57BL, Mice, Knockout, Alarmins metabolism, Caspase 1 physiology, Hematopoietic Stem Cell Mobilization, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells metabolism, Inflammation pathology, NLR Family, Pyrin Domain-Containing 3 Protein physiology
- Abstract
Like their homing after transplantation to bone marrow (BM), the mobilization of hematopoietic stem/progenitor cells (HSPCs) is still not fully understood, and several overlapping pathways are involved. Several years ago our group proposed that sterile inflammation in the BM microenvironment induced by pro-mobilizing agents is a driving force in this process. In favor of our proposal, both complement cascade (ComC)-deficient and Nlrp3 inflammasome-deficient mice are poor G-CSF and AMD3100 mobilizers. It is also known that the Nlrp3 inflammasome mediates its effects by activating caspase-1, which is responsible for proteolytic activation of interleukin-1β (IL-1β) and interleukin-18 (IL-18) and their release from cells along with several danger-associated molecular pattern molecules (DAMPs). We observed in the past that IL-1β and IL-18 independently promote mobilization of HSPCs. In the current work we demonstrated that caspase-1-KO mice are poor mobilizers, and, to our surprise, administration of IL-1β or IL-18, as in the case of Nlrp3-KO animals, does not correct this defect. Moreover, neither Caspase-1-KO nor Nlrp3-KO mice properly activated the ComC to execute the mobilization process. Interestingly, mobilization in these animals and activation of the ComC were both restored after injection of the DAMP cocktail eATP+HGMB1+S100A9, the components of which are normally released from cells in an Nlrp3 inflammasome-caspase-1-dependent manner. In addition, we report that caspase-1-deficient HSPCs show a decrease in migration in response to BM homing factors and engraft more poorly after transplantation. These results for the first time identify caspase-1 as an orchestrator of HSPC trafficking., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
7. Heme Oxygenase 1 (HO-1) as an Inhibitor of Trafficking of Normal and Malignant Hematopoietic Stem Cells - Clinical and Translational Implications.
- Author
-
Ratajczak MZ, Adamiak M, Ratajczak J, and Kucia M
- Subjects
- Bone Marrow metabolism, Inflammasomes metabolism, Stem Cell Niche, Hematopoietic Stem Cells, Heme Oxygenase-1 metabolism
- Abstract
Evidence indicates that bone marrow (BM)-residing hematopoietic stem/progenitor cells (HSPCs) are released into peripheral blood (PB) after administration of pro-mobilizing drugs, which induce a state of sterile inflammation in the BM microenvironment. In the reverse process, as seen after hematopoietic transplantation, intravenously injected HSPCs home and engraft into BM niches. Here again, conditioning for transplantation by myeloablative chemo- or radiotherapy induces a state of sterile inflammation that promotes HSPC seeding to BM stem cell niches. Therefore, the trafficking of HSPCs and their progeny, including granulocytes and monocytes/macrophages, is regulated by a response to pro-inflammatory stimuli. This responsiveness to inflammatory cues is also preserved after malignant transformation of hematopoietic cells. Results from our laboratory indicate that the responsiveness of hematopoietic cells to pro-inflammatory stimuli is orchestrated by Nlrp3 inflammasome. As reported, HO-1 effectively attenuates intracellular activation of Nlrp3 inflammasome as well as the pro-inflammatory effects of several humoral mediators, including complement cascade (ComC) cleavage fragments that promote migration of hematopoietic cells. Based on this finding, inhibition of HO-1 activity may become a practical strategy to enhance the mobilization and homing of normal HSPCs, and, alternatively, its activation may prevent unwanted spread and in vivo expansion of leukemic cells. Graphical Abstract.
- Published
- 2021
- Full Text
- View/download PDF
8. Nlrp3 Inflammasome Signaling Regulates the Homing and Engraftment of Hematopoietic Stem Cells (HSPCs) by Enhancing Incorporation of CXCR4 Receptor into Membrane Lipid Rafts.
- Author
-
Adamiak M, Abdel-Latif A, Bujko K, Thapa A, Anusz K, Tracz M, Brzezniakiewicz-Janus K, Ratajczak J, Kucia M, and Ratajczak MZ
- Subjects
- Adenosine Triphosphate pharmacology, Animals, Autocrine Communication, Bone Marrow Cells metabolism, Cell Movement drug effects, Cellular Microenvironment, Chemokine CXCL12 metabolism, Chemotactic Factors pharmacology, Connexins metabolism, Cytokines metabolism, Female, Hematopoietic Stem Cell Transplantation, Mice, Inbred C57BL, Mice, Knockout, Models, Biological, Nerve Tissue Proteins metabolism, Transplantation Conditioning, Hematopoietic Stem Cells metabolism, Inflammasomes metabolism, Membrane Lipids metabolism, Membrane Microdomains metabolism, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, Receptors, CXCR4 metabolism, Signal Transduction
- Abstract
Fast and efficient homing and engraftment of hematopoietic stem progenitor cells (HSPCs) is crucial for positive clinical outcomes from transplantation. We found that this process depends on activation of the Nlrp3 inflammasome, both in the HSPCs to be transplanted and in the cells in the recipient bone marrow (BM) microenvironment. For the first time we provide evidence that functional deficiency in the Nlrp3 inflammasome in transplanted cells or in the host microenvironment leads to defective homing and engraftment. At the molecular level, functional deficiency of the Nlrp3 inflammasome in HSPCs leads to their defective migration in response to the major BM homing chemoattractant stromal-derived factor 1 (SDF-1) and to other supportive chemoattractants, including sphingosine-1-phosphate (S1P) and extracellular adenosine triphosphate (eATP). We report that activation of the Nlrp3 inflammasome increases autocrine release of eATP, which promotes incorporation of the CXCR4 receptor into membrane lipid rafts at the leading surface of migrating cells. On the other hand, a lack of Nlrp3 inflammasome expression in BM conditioned for transplantation leads to a decrease in expression of SDF-1 and danger-associated molecular pattern molecules (DAMPs), which are responsible for activation of the complement cascade (ComC), which in turn facilitates the homing and engraftment of HSPCs.
- Published
- 2020
- Full Text
- View/download PDF
9. Pannexin-1 channel "fuels" by releasing ATP from bone marrow cells a state of sterile inflammation required for optimal mobilization and homing of hematopoietic stem cells.
- Author
-
Cymer M, Brzezniakiewicz-Janus K, Bujko K, Thapa A, Ratajczak J, Anusz K, Tracz M, Jackowska-Tracz A, Ratajczak MZ, and Adamiak M
- Subjects
- Animals, Bone Marrow metabolism, Inflammasomes metabolism, Mice, Adenosine Triphosphate metabolism, Bone Marrow Cells metabolism, Connexins metabolism, Hematopoietic Stem Cells metabolism, Inflammation metabolism, Nerve Tissue Proteins metabolism
- Abstract
An efficient harvest of hematopoietic stem/progenitor cells (HSPCs) after pharmacological mobilization from the bone marrow (BM) into peripheral blood (PB) and subsequent proper homing and engraftment of these cells are crucial for clinical outcomes from hematopoietic transplants. Since extracellular adenosine triphosphate (eATP) plays an important role in both processes as an activator of sterile inflammation in the bone marrow microenvironment, we focused on the role of Pannexin-1 channel in the secretion of ATP to trigger both egress of HSPCs out of BM into PB as well as in reverse process that is their homing to BM niches after transplantation into myeloablated recipient. We employed a specific blocking peptide against Pannexin-1 channel and noticed decreased mobilization efficiency of HSPCs as well as other types of BM-residing stem cells including mesenchymal stroma cells (MSCs), endothelial progenitors (EPCs), and very small embryonic-like stem cells (VSELs). To explain better a role of Pannexin-1, we report that eATP activated Nlrp3 inflammasome in Gr-1
+ and CD11b+ cells enriched for granulocytes and monocytes. This led to release of danger-associated molecular pattern molecules (DAMPs) and mitochondrial DNA (miDNA) that activate complement cascade (ComC) required for optimal egress of HSPCs from BM. On the other hand, Pannexin-1 channel blockage in transplant recipient mice leads to a defect in homing and engraftment of HSPCs. Based on this, Pannexin-1 channel as a source of eATP plays an important role in HSPCs trafficking.- Published
- 2020
- Full Text
- View/download PDF
10. A Novel Evidence That Mannan Binding Lectin (MBL) Pathway of Complement Cascade Activation is Involved in Homing and Engraftment of Hematopoietic Stem Progenitor Cells (HSPCs).
- Author
-
Adamiak M, Cymer M, Anusz K, Tracz M, and Ratajczak MZ
- Subjects
- Animals, Biomarkers metabolism, Bone Marrow metabolism, Chemokine CXCL12 metabolism, Chemotaxis drug effects, Culture Media, Conditioned pharmacology, Inflammasomes metabolism, Mice, Inbred C57BL, Mice, Knockout, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, Complement Activation drug effects, Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells metabolism, Mannose-Binding Lectin metabolism
- Abstract
Delayed homing and engraftment of hematopoietic stem progenitor cells (HSPCs) or even failure to engraft at all is significant clinical problem after hematopoietic transplant. Therefore, in order to develop more efficient homing and engraftment facilitating strategies it is important to learn more about this process. Our team has postulated that myeloablative conditioning for transplantation induces in bone marrow (BM) microenvironment a state of sterile inflammation in which elements of innate immunity activated by radio- or chemotherapy conditioning for transplant play an important role. In frame with this claim we reported that a significant role in this process plays activation of complement cascade (ComC). Accordingly, mice that that lack a fifth component (C5) of ComC turned out to engraft poorly with normal syngeneic BM cells as compared to normal control animals. In extension of our previous studies we provide for first time evidence that mannan binding lectin (MBL) pathway is involved in activation of ComC in myeloablated transplant recipient BM and thus plays an important role in homing and engraftment of HSPCs. To support this MBL-KO mice show significant defect in hematopoietic reconstitution after hematopoietic transplantation. This correlates with a decrease in expression of stromal derived factor-1 (SDF-1) and impaired activation of Nlrp3 inflammasome in irradiated BM of these mice.
- Published
- 2020
- Full Text
- View/download PDF
11. The Nlrp3 inflammasome as a "rising star" in studies of normal and malignant hematopoiesis.
- Author
-
Ratajczak MZ, Bujko K, Cymer M, Thapa A, Adamiak M, Ratajczak J, Abdel-Latif AK, and Kucia M
- Subjects
- Animals, Humans, Myelodysplastic Syndromes metabolism, Hematopoiesis physiology, Hematopoietic Stem Cells metabolism, Inflammasomes metabolism, NLR Family, Pyrin Domain-Containing 3 Protein metabolism
- Abstract
Recent investigations indicate that hematopoiesis is coregulated by innate immunity signals and by pathways characteristic of the activation of innate immunity cells that also operate in normal hematopoietic stem progenitor cells (HSPCs). This should not be surprising because of the common developmental origin of these cells from a hemato/lymphopoietic stem cell. An important integrating factor is the Nlrp3 inflammasome, which has emerged as a major sensor of changes in body microenvironments, cell activation, and cell metabolic activity. It is currently the best-studied member of the inflammasome family expressed in hematopoietic and lymphopoietic cells, including also HSPCs. It is proposed as playing a role in (i) the development and expansion of HSPCs, (ii) their release from bone marrow (BM) into peripheral blood (PB) in stress situations and during pharmacological mobilization, (iii) their homing to BM after transplantation, and (iv) their aging and the regulation of hematopoietic cell metabolism. The Nlrp3 inflammasome is also involved in certain hematological pathologies, including (i) myelodysplastic syndrome, (ii) myeloproliferative neoplasms, (iii) leukemia, and (iv) graft-versus-host disease (GvHD) after transplantation. The aim of this review is to shed more light on this intriguing intracellular protein complex that has become a "rising star" in studies focused on both normal steady-state and pathological hematopoiesis.
- Published
- 2020
- Full Text
- View/download PDF
12. Innate immunity orchestrates the mobilization and homing of hematopoietic stem/progenitor cells by engaging purinergic signaling-an update.
- Author
-
Ratajczak MZ, Adamiak M, Bujko K, Thapa A, Pensato V, Kucia M, Ratajczak J, and Ulrich H
- Subjects
- Animals, Bone Marrow immunology, Cell Movement immunology, Cell Movement physiology, Hematopoietic Stem Cells immunology, Humans, Bone Marrow metabolism, Hematopoietic Stem Cell Mobilization methods, Hematopoietic Stem Cells metabolism, Immunity, Innate immunology
- Abstract
Bone marrow (BM) as an active hematopoietic organ is highly sensitive to changes in body microenvironments and responds to external physical stimuli from the surrounding environment. In particular, BM tissue responds to several cues related to infections, strenuous exercise, tissue/organ damage, circadian rhythms, and physical challenges such as irradiation. These multiple stimuli affect BM cells to a large degree through a coordinated response of the innate immunity network as an important guardian for maintaining homeostasis of the body. In this review, we will foc++us on the role of purinergic signaling and innate immunity in the trafficking of hematopoietic stem/progenitor cells (HSPCs) during their egression from the BM into peripheral blood (PB), as seen along pharmacological mobilization, and in the process of homing and subsequent engraftment into BM after hematopoietic transplantation. Innate immunity mediates these processes by engaging, in addition to certain peptide-based factors, other important non-peptide mediators, including bioactive phosphosphingolipids and extracellular nucleotides, as the main topic of this review. Elucidation of these mechanisms will allow development of more efficient stem cell mobilization protocols to harvest the required number of HSPCs for transplantation and to accelerate hematopoietic reconstitution in transplanted patients.
- Published
- 2020
- Full Text
- View/download PDF
13. Novel Evidence that Purinergic Signaling - Nlrp3 Inflammasome Axis Regulates Circadian Rhythm of Hematopoietic Stem/Progenitor Cells Circulation in Peripheral Blood.
- Author
-
Adamiak M, Ciechanowicz A, Skoda M, Cymer M, Tracz M, Xu B, and Ratajczak MZ
- Subjects
- Adaptor Proteins, Signal Transducing metabolism, Adenosine Triphosphate blood, Animals, Apoptosis Regulatory Proteins metabolism, Connexins metabolism, DNA-Binding Proteins metabolism, Endothelial Progenitor Cells metabolism, Extracellular Space metabolism, Gene Expression Regulation, Mesenchymal Stem Cells metabolism, Mice, Mice, Inbred C57BL, Mouse Embryonic Stem Cells cytology, Nerve Tissue Proteins metabolism, Nuclear Receptor Subfamily 1, Group D, Member 1 metabolism, Cell Movement, Circadian Rhythm genetics, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells metabolism, Inflammasomes metabolism, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, Purines metabolism, Signal Transduction
- Abstract
We found that circadian changes in ATP level in peripheral blood (PB) activate the Nlrp3 inflammasome, which triggers diurnal release of hematopoietic stem/progenitor cells (HSPCs) from murine bone marrow (BM) into PB. Consistent with this finding, we observed circadian changes in expression of mRNA for Nlrp3 inflammasome-related genes, including Nlrp3, caspase 1, IL-1β, IL-18, gasdermin (GSDMD), HMGB1, and S100A9. Circadian release of HSPCs from BM into PB as well as expression of Nlrp3-associated genes was decreased in mice in which pannexin 1-mediated secretion of ATP was inhibited by the blocking peptide 10Panx and in animals exposed to the specific small-molecule inhibitor of the Nlrp3 inflammasome MCC950. In addition to HSPCs, a similar decrease in diurnal cell counts was observed for mesenchymal stromal cells (MSCs), endothelial progenitor cells (EPCs), and very small embryonic-like stem cells (VSELs). These results shed more light on the complexity of circadian regulation of HSPC release into PB, which is coordinated in a purinergic signaling-, innate immunity-dependent manner. Moreover, in addition to circadian changes in expression of the Nlrp3 inflammasome we also observed diurnal changes in expression of other inflammasomes, including Aim2, Nrp1a, and Nlrp1b.
- Published
- 2020
- Full Text
- View/download PDF
14. An Overview of Novel Unconventional Mechanisms of Hematopoietic Development and Regulators of Hematopoiesis - a Roadmap for Future Investigations.
- Author
-
Bujko K, Cymer M, Adamiak M, and Ratajczak MZ
- Subjects
- Animals, Humans, Hematopoiesis, Hematopoietic Stem Cell Mobilization, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells physiology
- Abstract
Hematopoietic stem cells (HSCs) are the best-characterized stem cells in adult tissues. Nevertheless, as of today, many open questions remain. First, what is the phenotype of the most primitive "pre-HSC" able to undergo asymmetric divisions during ex vivo expansion that gives rise to HSC for all hemato-lymphopoietic lineages. Next, most routine in vitro assays designed to study HSC specification into hematopoietic progenitor cells (HPCs) for major hematopoietic lineages are based on a limited number of peptide-based growth factors and cytokines, neglecting the involvement of several other regulators that are endowed with hematopoietic activity. Examples include many hormones, such as pituitary gonadotropins, gonadal sex hormones, IGF-1, and thyroid hormones, as well as bioactive phosphosphingolipids and extracellular nucleotides (EXNs). Moreover, in addition to regulation by stromal-derived factor 1 (SDF-1), trafficking of these cells during mobilization or homing after transplantation is also regulated by bioactive phosphosphingolipids, EXNs, and three ancient proteolytic cascades, the complement cascade (ComC), the coagulation cascade (CoA), and the fibrinolytic cascade (FibC). Finally, it has emerged that bone marrow responds by "sterile inflammation" to signals sent from damaged organs and tissues, systemic stress, strenuous exercise, gut microbiota, and the administration of certain drugs. This review will address the involvement of these unconventional regulators and present a broader picture of hematopoiesis.
- Published
- 2019
- Full Text
- View/download PDF
15. Novel evidence that an alternative complement cascade pathway is involved in optimal mobilization of hematopoietic stem/progenitor cells in Nlrp3 inflammasome-dependent manner.
- Author
-
Adamiak M, Lenkiewicz AM, Cymer M, Kucia M, Ratajczak J, and Ratajczak MZ
- Subjects
- Animals, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells immunology, Humans, Immunity, Innate, Mice, Complement Activation immunology, Complement System Proteins immunology, Complement System Proteins metabolism, Hematopoietic Stem Cell Mobilization, Hematopoietic Stem Cells metabolism, NLR Family, Pyrin Domain-Containing 3 Protein metabolism
- Published
- 2019
- Full Text
- View/download PDF
16. The Inhibition of CD39 and CD73 Cell Surface Ectonucleotidases by Small Molecular Inhibitors Enhances the Mobilization of Bone Marrow Residing Stem Cells by Decreasing the Extracellular Level of Adenosine.
- Author
-
Adamiak M, Bujko K, Brzezniakiewicz-Janus K, Kucia M, Ratajczak J, and Ratajczak MZ
- Subjects
- Animals, Antigens, CD, Bone Marrow metabolism, Cell Movement, Cells, Cultured, Embryonic Stem Cells cytology, Embryonic Stem Cells drug effects, Embryonic Stem Cells metabolism, Endothelial Progenitor Cells cytology, Endothelial Progenitor Cells drug effects, Endothelial Progenitor Cells metabolism, Hematopoietic Stem Cells drug effects, Hematopoietic Stem Cells metabolism, Mesenchymal Stem Cells cytology, Mesenchymal Stem Cells drug effects, Mesenchymal Stem Cells metabolism, Mice, Mice, Inbred C57BL, Signal Transduction, Vasodilator Agents metabolism, 5'-Nucleotidase antagonists & inhibitors, Adenosine deficiency, Apyrase antagonists & inhibitors, Bone Marrow drug effects, Hematopoietic Stem Cell Mobilization methods, Hematopoietic Stem Cells cytology, Small Molecule Libraries pharmacology
- Abstract
We have recently demonstrated that purinergic signaling in bone marrow (BM) microenvironment regulates mobilization of hematopoietic stem progenitor cells (HSPCs), mesenchymal stroma cells (MSCs), endothelial progenitor cells (EPCs), and very small embryonic like stem cells (VSELs) into the peripheral blood (PB). While extracellular adenosine triphosphate (ATP) promotes mobilization, its metabolite extracellular adenosine has an opposite effect. Since ATP is processed in extracellular space to adenosine by ectonucleotidases including cell surface expressed CD39 and CD73, we asked if inhibition of these enzymes by employing in vivo small molecular inhibitors ARL67156 and AMPCP of CD39 and CD73 respectively, alone or combined could enhance granulocyte stimulating factor (G-CSF)- and AMD3100-induced pharmacological mobilization of stem cells. Herein we report that pre-treatment of donor mice with CD39 and CD73 inhibitors facilitates the mobilization of HSPCs as well as other types of BM-residing stem cells. This data on one hand supports the role of purinergic signaling in stem cell trafficking, and on the other since both compounds are not toxic against human cells, they could be potentially employed in the clinic to enhance the mobilization of BM residing stem cells for clinical purposes.
- Published
- 2019
- Full Text
- View/download PDF
17. The Nlrp3 Inflammasome Orchestrates Mobilization of Bone Marrow-Residing Stem Cells into Peripheral Blood.
- Author
-
Lenkiewicz AM, Adamiak M, Thapa A, Bujko K, Pedziwiatr D, Abdel-Latif AK, Kucia M, Ratajczak J, and Ratajczak MZ
- Subjects
- Animals, Endothelial Progenitor Cells cytology, Furans, Hematopoietic Stem Cell Mobilization, Hematopoietic Stem Cells cytology, Heterocyclic Compounds, 4 or More Rings pharmacology, Immunity, Innate drug effects, Indenes, Inflammasomes agonists, Inflammasomes antagonists & inhibitors, Interleukin-18 metabolism, Interleukin-1beta metabolism, Mesenchymal Stem Cells cytology, Mice, NLR Family, Pyrin Domain-Containing 3 Protein agonists, NLR Family, Pyrin Domain-Containing 3 Protein antagonists & inhibitors, Nigericin pharmacology, Sulfonamides, Sulfones pharmacology, Endothelial Progenitor Cells metabolism, Hematopoietic Stem Cells metabolism, Inflammasomes metabolism, Mesenchymal Stem Cells metabolism, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, Stem Cell Niche
- Abstract
Mobilization of stem cells from bone marrow (BM) into peripheral blood (PB) in response to tissue or organ injury, infections, strenuous exercise, or mobilization-inducing drugs is as we postulated result of a "sterile inflammation" in the BM microenvironment that triggers activation of the Complement Cascade (ComC). Therefore, we became interested in the role of the Nlrp3 inflammasome in this process and show for the first time that its activation in ATP-dependent manner orchestrates BM egress of hematopoietic stem/progenitor cells (HSPCs) as well as other stem cells, including mesenchymal stroma cells (MSCs), endothelial progenitor cells (EPCs), and very small embryonic-like stem cells (VSELs). To explain this extracellular ATP is a potent activator of the Nrlp3 inflammasome, which leads to the release of interleukin 1β and interleukin 18, as well as several danger-associated molecular pattern molecules (DAMPs) that activate the mannan-binding lectin (MBL) pathway of the ComC, from cells of the innate immunity network. In support of this mechanism, we demonstrate that the Nlrp3 inflammasome become activated in innate immunity cells by granulocyte colony stimulating factor (G-CSF) and AMD3100 in an ATP-dependent manner. Moreover, administration of the Nlrp3 inflammasome activator nigericin induces mobilization in mice, and the opposite effect is obtained by administration of an Nlrp3 inhibitor (MCC950) to mice mobilized by G-CSF or AMD3100. In summary, our results further support the crucial role of innate immunity, BM sterile inflammation, and novel role of the ATP-Nlrp3-ComC axis in the egress of stem cells into PB.
- Published
- 2019
- Full Text
- View/download PDF
18. Inducible Nitric Oxide Synthase (iNOS) Is a Novel Negative Regulator of Hematopoietic Stem/Progenitor Cell Trafficking.
- Author
-
Adamiak M, Abdelbaset-Ismail A, Moore JB 4th, Zhao J, Abdel-Latif A, Wysoczynski M, and Ratajczak MZ
- Subjects
- Animals, Blotting, Western, Bone Marrow Cells metabolism, Cell Adhesion genetics, Cell Line, Tumor, Cells, Cultured, Chemotaxis genetics, Female, Hematopoietic Stem Cell Mobilization methods, Hematopoietic Stem Cells cytology, Heme Oxygenase-1 genetics, Heme Oxygenase-1 metabolism, Humans, K562 Cells, Mice, Inbred C57BL, Mice, Knockout, Nitric Oxide metabolism, Nitric Oxide Synthase Type II metabolism, RNA Interference, Reverse Transcriptase Polymerase Chain Reaction, Cell Movement genetics, Gene Expression Regulation, Enzymologic, Hematopoietic Stem Cells metabolism, Nitric Oxide Synthase Type II genetics
- Abstract
Nitric oxide (NO) is a gaseous free radical molecule involved in several biological processes related to inflammation, tissue damage, and infections. Based on reports that NO inhibits migration of granulocytes and monocytes, we became interested in the role of inducible NO synthetase (iNOS) in pharmacological mobilization of hematopoietic stem/progenitor cells (HSPCs) from bone marrow (BM) into peripheral blood (PB). To address the role of NO in HSPC trafficking, we upregulated or downregulated iNOS expression in hematopoietic cell lines. Next, we performed mobilization studies in iNOS
-/- mice and evaluated engraftment of iNOS-/- HSPCs in wild type (control) animals. Our results indicate that iNOS is a novel negative regulator of hematopoietic cell migration and prevents egress of HSPCs into PB during mobilization. At the molecular level, downregulation of iNOS resulted in downregulation of heme oxygenase 1 (HO-1), and, conversely, upregulation of iNOS enhanced HO-1 activity. Since HO-1 is a negative regulator of cell migration, the inhibitory effects of iNOS identified by us can be at least partially explained by its enhancing the HO-1 level in BM cells.- Published
- 2017
- Full Text
- View/download PDF
19. Poor Mobilization in T-Cell-Deficient Nude Mice Is Explained by Defective Activation of Granulocytes and Monocytes.
- Author
-
Wysoczynski M, Adamiak M, Suszynska M, Abdel-Latif A, Ratajczak J, and Ratajczak MZ
- Subjects
- Animals, Benzylamines, Bone Marrow Cells cytology, Bone Marrow Cells metabolism, Cyclams, Female, Flow Cytometry, Granulocyte Colony-Stimulating Factor metabolism, Granulocytes cytology, Hematopoietic Stem Cell Mobilization methods, Hematopoietic Stem Cells cytology, Heterocyclic Compounds pharmacology, Immunoglobulin M metabolism, Mice, Mice, Inbred BALB C, Mice, Nude, Mice, SCID, Monocytes cytology, Granulocytes metabolism, Hematopoietic Stem Cells metabolism, Monocytes metabolism
- Abstract
It has been reported that both SCID mice and SCID patients poorly mobilize hematopoietic stem/progenitor cells (HSPCs) in response to granulocyte colony-stimulating factor (G-CSF). This defect has been proposed to result from a lack of naturally occurring IgM immunoglobulins to trigger activation of the complement cascade (ComC) and release of C5 cleavage fragments crucial in the mobilization process. However, SCID individuals also have T-cell deficiency, and T cells have been shown to modulate trafficking of HSPCs. To learn more about the role of T lymphocytes, we performed mobilization studies in T-lymphocyte-deficient nude mice and found that these mice respond poorly to G-CSF and zymosan but are normal mobilizers in response to AMD3100. Since nude mice have normal levels of IgM immunoglobulins in peripheral blood and may activate the ComC, we focused on the potential involvement of Gr1+ granulocytes and monocytes, which show defective maturation in these animals. Using a nude mouse mobilization model, we found further support for the proposition that proper function of Gr1+ cells is crucial for optimal mobilization of HSPCs.
- Published
- 2017
- Full Text
- View/download PDF
20. The Involvment of Hematopoietic-Specific PLC -β2 in Homing and Engraftment of Hematopoietic Stem/Progenitor Cells.
- Author
-
Adamiak M, Suszynska M, Abdel-Latif A, Abdelbaset-Ismail A, Ratajczak J, and Ratajczak MZ
- Subjects
- Adenosine Triphosphate pharmacology, Animals, Blotting, Western, Bone Marrow Cells cytology, Bone Marrow Cells enzymology, Calcium metabolism, Cell Adhesion drug effects, Cells, Cultured, Ceramides pharmacology, Chemokine CXCL12 pharmacology, Chemotaxis drug effects, Female, Fibronectins pharmacology, Gene Expression, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells metabolism, Heme Oxygenase-1 genetics, Heme Oxygenase-1 metabolism, Leukocytes, Mononuclear cytology, Leukocytes, Mononuclear enzymology, Lysophospholipids pharmacology, Mice, Inbred C57BL, Mice, Knockout, Phospholipase C beta genetics, Reverse Transcriptase Polymerase Chain Reaction, Sphingosine analogs & derivatives, Sphingosine pharmacology, Cell Movement, Hematopoietic Stem Cell Transplantation methods, Hematopoietic Stem Cells enzymology, Phospholipase C beta metabolism
- Abstract
Migration and bone marrow (BM) homing of hematopoietic stem progenitor cells (HSPCs) is regulated by several signaling pathways, and here we provide evidence for the involvement in this process of hematopoietic-specific phospholipase C-β2 (PLC-β2). This enzyme is involved in release of intracellular calcium and activation of protein kinase C (PKC). Recently we reported that PLC-β2 promotes mobilization of HSPCs from BM into peripheral blood (PB), and this effect is mediated by the involvement of PLC-β2 in the release of proteolytic enzymes from granulocytes and its role in disintegration of membrane lipid rafts. Here we report that, besides the role of PLC-β2 in the release of HSPCs from BM niches, PLC-β2 regulates the migration of HSPCs in response to chemotactic gradients of BM homing factors, including SDF-1, S1P, C1P, and ATP. Specifically, HSPCs from PLC-β2-KO mice show impaired homing and engraftment in vivo after transplantation into lethally irradiated mice. This decrease in migration of HSPCs can be explained by impaired calcium release in PLC-β2-KO mice and a high baseline level of heme oxygenase 1 (HO-1), an enzyme that negatively regulates cell migration., Competing Interests: The authors declare no potential conflicts of interest.
- Published
- 2016
- Full Text
- View/download PDF
21. Evidence that a lipolytic enzyme--hematopoietic-specific phospholipase C-β2--promotes mobilization of hematopoietic stem cells by decreasing their lipid raft-mediated bone marrow retention and increasing the promobilizing effects of granulocytes.
- Author
-
Adamiak M, Poniewierska-Baran A, Borkowska S, Schneider G, Abdelbaset-Ismail A, Suszynska M, Abdel-Latif A, Kucia M, Ratajczak J, and Ratajczak MZ
- Subjects
- Animals, Apoptosis, Cell Adhesion, Cell Movement, Cell Proliferation, Cells, Cultured, Flow Cytometry, Granulocytes cytology, Hematopoietic Stem Cells cytology, Humans, Immunoenzyme Techniques, Mice, Mice, Inbred C57BL, Mice, Knockout, Signal Transduction, Bone Marrow enzymology, Complement C5a metabolism, Granulocytes metabolism, Hematopoietic Stem Cell Mobilization, Hematopoietic Stem Cells metabolism, Membrane Microdomains, Phospholipase C beta physiology
- Abstract
Hematopoietic stem/progenitor cells (HSPCs) reside in the bone marrow (BM) microenvironment and are retained there by the interaction of membrane lipid raft-associated receptors, such as the α-chemokine receptor CXCR4 and the α4β1-integrin (VLA-4, very late antigen 4 receptor) receptor, with their respective specific ligands, stromal-derived factor 1 and vascular cell adhesion molecule 1, expressed in BM stem cell niches. The integrity of the lipid rafts containing these receptors is maintained by the glycolipid glycosylphosphatidylinositol anchor (GPI-A). It has been reported that a cleavage fragment of the fifth component of the activated complement cascade, C5a, has an important role in mobilizing HSPCs into the peripheral blood (PB) by (i) inducing degranulation of BM-residing granulocytes and (ii) promoting their egress from the BM into the PB so that they permeabilize the endothelial barrier for subsequent egress of HSPCs. We report here that hematopoietic cell-specific phospholipase C-β2 (PLC-β2) has a crucial role in pharmacological mobilization of HSPCs. On the one hand, when released during degranulation of granulocytes, it digests GPI-A, thereby disrupting membrane lipid rafts and impairing retention of HSPCs in BM niches. On the other hand, it is an intracellular enzyme required for degranulation of granulocytes and their egress from BM. In support of this dual role, we demonstrate that PLC-β2-knockout mice are poor mobilizers and provide, for the first time, evidence for the involvement of this lipolytic enzyme in the mobilization of HSPCs.
- Published
- 2016
- Full Text
- View/download PDF
22. Downregulation of Heme Oxygenase 1 (HO-1) Activity in Hematopoietic Cells Enhances Their Engraftment After Transplantation.
- Author
-
Adamiak M, Moore JB 4th, Zhao J, Abdelbaset-Ismail A, Grubczak K, Rzeszotek S, Wysoczynski M, and Ratajczak MZ
- Subjects
- Animals, Blood Cell Count, Cell Adhesion drug effects, Cell Line, Tumor, Chemokine CXCL12 pharmacology, Chemotaxis drug effects, Enzyme Inhibitors pharmacology, Fetal Blood cytology, Hematopoietic Stem Cells drug effects, Heme Oxygenase-1 antagonists & inhibitors, Humans, Lysophospholipids pharmacology, Mice, Inbred C57BL, Mice, Knockout, Sphingosine analogs & derivatives, Sphingosine pharmacology, Down-Regulation drug effects, Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cells enzymology, Heme Oxygenase-1 metabolism
- Abstract
Heme oxygenase 1 (HO-1) is an inducible stress-response enzyme that not only catalyzes the degradation of heme (e.g., released from erythrocytes) but also has an important function in various physiological and pathophysiological states associated with cellular stress, such as ischemic/reperfusion injury. HO-1 has a well-documented anti-inflammatory potential, and HO-1 has been reported to have a negative effect on adhesion and migration of neutrophils in acute inflammation in a model of peritonitis. This finding is supported by our recent observation that hematopoietic stem progenitor cells (HSPCs) from HO-1 KO mice are easy mobilizers, since they respond better to peripheral blood chemotactic gradients than wild-type littermates. Based on these findings, we hypothesized that transient inhibition of HO-1 by nontoxic small-molecule inhibitors would enhance migration of HSPCs in response to bone marrow chemoattractants and thereby facilitate their homing. To directly address this issue, we generated several human hematopoietic cell lines in which HO-1 was upregulated or downregulated. We also exposed murine and human BM-derived cells to small-molecule activators and inhibitors of HO-1. Our results indicate that HO-1 is an inhibitor of hematopoietic cell migration in response to crucial BM homing chemoattractants such as stromal-derived factor 1 (SDF-1) and sphingosine-1-phosphate (S1P). Most importantly, our in vitro and in vivo animal experiments demonstrate for the first time that transiently inhibiting HO-1 activity in HSPCs by small-molecule inhibitors improves HSPC engraftment. We propose that this simple and inexpensive strategy could be employed in the clinical setting to improve engraftment of HSPCs, particularly in those situations in which the number of HSPCs available for transplant is limited (e.g., when transplanting umbilical cord blood).
- Published
- 2016
- Full Text
- View/download PDF
23. Human haematopoietic stem/progenitor cells express several functional sex hormone receptors.
- Author
-
Abdelbaset-Ismail A, Suszynska M, Borkowska S, Adamiak M, Ratajczak J, Kucia M, and Ratajczak MZ
- Subjects
- Cell Adhesion, Cell Proliferation, Cells, Cultured, Fetal Blood, Fibronectins metabolism, Gonadal Steroid Hormones physiology, Humans, Hematopoietic Stem Cells metabolism, Human Umbilical Vein Endothelial Cells metabolism, Receptors, G-Protein-Coupled metabolism, Receptors, Steroid metabolism
- Abstract
Evidence has accumulated that murine haematopoietic stem/progenitor cells (HSPCs) share several markers with the germline, a connection supported by recent reports that pituitary and gonadal sex hormones (SexHs) regulate development of murine HSPCs. It has also been reported that human HSPCs, like their murine counterparts, respond to certain SexHs (e.g. androgens). However, to better address the effects of SexHs, particularly pituitary SexHs, on human haematopoiesis, we tested for expression of receptors for pituitary SexHs, including follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin (PRL), as well as the receptors for gonadal SexHs, including progesterone, oestrogens, and androgen, on HSPCs purified from human umbilical cord blood (UCB) and peripheral blood (PB). We then tested the functionality of these receptors in ex vivo signal transduction studies and in vitro clonogenic assays. In parallel, we tested the effect of SexHs on human mesenchymal stromal cells (MSCs). Finally, based on our observation that at least some of the UCB-derived, CD45(-) very small embryonic-like stem cells (VSELs) become specified into CD45(+) HSPCs, we also evaluated the expression of pituitary and gonadal SexH receptors on these cells. We report for the first time that human HSPCs and VSELs, like their murine counterparts, express pituitary and gonadal SexH receptors at the mRNA and protein levels. Most importantly, SexH if added to suboptimal doses of haematopoietic cytokines and growth factors enhance clonogenic growth of human HSPCs as well as directly stimulate proliferation of MSCs., (© 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.)
- Published
- 2016
- Full Text
- View/download PDF
24. Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow.
- Author
-
Adamiak M, Borkowska S, Wysoczynski M, Suszynska M, Kucia M, Rokosh G, Abdel-Latif A, Ratajczak J, and Ratajczak MZ
- Subjects
- Animals, Chemokine CXCL12 metabolism, Female, Male, Mice, Phosphotransferases (Alcohol Group Acceptor) metabolism, Receptors, CXCR4 genetics, Receptors, CXCR4 metabolism, Signal Transduction, Sphingosine metabolism, Stem Cell Niche physiology, Bone Marrow Cells cytology, Bone Marrow Cells metabolism, Hematopoietic Stem Cell Transplantation methods, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells metabolism, Lysophospholipids metabolism, Sphingosine analogs & derivatives, Transplantation Conditioning methods
- Abstract
The α-chemokine stromal-derived factor 1 (SDF-1), which binds to the CXCR4 receptor, directs migration and homing of CXCR4+ hematopoietic stem/progenitor cells (HSPCs) to bone marrow (BM) stem cell niches. Nevertheless, it is also known that CXCR4-/- fetal liver-derived hematopoietic stem cells engraft into BM and that blockade of CXCR4 by its antagonist AMD3100 does not prevent engraftment of HSPCs. Because of this finding of SDF-1-CXCR4-independent BM homing, the unique role of SDF-1 in HSPC homing has recently been challenged. While SDF-1 is the only chemokine that chemoattracts HSPCs, other chemoattractants for these cells have recently been described, including the bioactive phosphosphingolipid sphingosine-1-phosphate (S1P). To address the potential role of S1P in homing of HSPCs to BM, we performed hematopoietic transplants into mice deficient in BM-expressed sphingosine kinase 1 (Sphk1-/-) using hematopoietic cells from normal control mice as well as cells from mice in which floxed CXCR4 (CXCR4fl/fl) was conditionally deleted. We observed the presence of a homing and engraftment defect in HSPCs of Sphk1-/- mice that was particularly profound after transplantation of CXCR4-/- BM cells. Thus, our results indicate that BM-microenvironment-expressed S1P plays a role in homing of HSPCs. They also support the concept that, in addition to the SDF-1-CXCR4 axis, other chemotactic axes are also involved in homing and engraftment of HSPCs.
- Published
- 2015
- Full Text
- View/download PDF
25. Hematopoietic stem/progenitor cells express several functional sex hormone receptors-novel evidence for a potential developmental link between hematopoiesis and primordial germ cells.
- Author
-
Mierzejewska K, Borkowska S, Suszynska E, Suszynska M, Poniewierska-Baran A, Maj M, Pedziwiatr D, Adamiak M, Abdel-Latif A, Kakar SS, Ratajczak J, Kucia M, and Ratajczak MZ
- Subjects
- Animals, Cells, Cultured, Female, Hematopoietic Stem Cells cytology, Leukocyte Common Antigens genetics, Leukocyte Common Antigens metabolism, Male, Mice, Mice, Inbred C57BL, Receptors, Androgen genetics, Receptors, FSH genetics, Receptors, LH genetics, Receptors, Prolactin genetics, Germ Cells metabolism, Hematopoiesis, Hematopoietic Stem Cells metabolism, Receptors, Androgen metabolism, Receptors, FSH metabolism, Receptors, LH metabolism, Receptors, Prolactin metabolism
- Abstract
Evidence has accumulated that hematopoietic stem progenitor cells (HSPCs) share several markers with the germline, a connection supported by reports that prolactin, androgens, and estrogens stimulate hematopoiesis. To address this issue more directly, we tested the expression of receptors for pituitary-derived hormones, such as follicle-stimulating hormone (FSH) and luteinizing hormone (LH), on purified murine bone marrow (BM) cells enriched for HSPCs and tested the functionality of these receptors in ex vivo signal transduction studies and in vitro clonogenic assays. We also tested whether administration of pituitary- and gonad-derived sex hormones (SexHs) increases incorporation of bromodeoxyuridine (BrdU) into HSPCs and expansion of hematopoietic clonogenic progenitors in mice and promotes recovery of blood counts in sublethally irradiated animals. We report for the first time that HSPCs express functional FSH and LH receptors and that both proliferate in vivo and in vitro in response to stimulation by pituitary SexHs. Furthermore, based on our observations that at least some of CD45(-) very small embryonic-like stem cells (VSELs) may become specified into CD45(+) HSPCs, we also evaluated the expression of pituitary and gonadal SexHs receptors on these cells and tested whether these quiescent cells may expand in vivo in response to SexHs administration. We found that VSELs express SexHs receptors and respond in vivo to SexHs stimulation, as evidenced by BrdU accumulation. Since at least some VSELs share several markers characteristic of migrating primordial germ cells and can be specified into HSPCs, this observation sheds new light on the BM stem cell hierarchy.
- Published
- 2015
- Full Text
- View/download PDF
26. The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing—a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking
- Author
-
Daryl L. Davies, Kamila Bujko, Janina Ratajczak, Valentina Pensato, Mateusz Adamiak, Arjun Thapa, Mariusz Z. Ratajczak, Henning Ulrich, Katarzyna Brzezniakiewicz-Janus, Magda Kucia, Adamiak M., Bujko K., Thapa A., Pensato V., Brzezniakiewicz-Janus K., Ratajczak J., Davies D.L., Ulrich H., Kucia M., and Ratajczak M.Z.
- Subjects
Cancer Research ,medicine.drug_class ,Haematopoietic stem cells, Medical research ,Biology ,Mice ,Granulocyte Colony-Stimulating Factor ,medicine ,Animals ,Humans ,Stem Cell Niche ,Progenitor cell ,Receptor ,Mice, Knockout ,Chemotaxis ,Purinergic receptor ,Hematopoietic Stem Cell Transplantation ,ADENOSINA ,Hematology ,Purinergic signalling ,Hematopoietic Stem Cells ,Receptor antagonist ,Hematopoietic Stem Cell Mobilization ,Cell biology ,Mice, Inbred C57BL ,Transplantation ,Oncology ,Female ,Receptors, Purinergic P2X7 ,Stem cell ,Receptors, Purinergic P2X4 ,Signal Transduction ,Homing (hematopoietic) - Abstract
Recent evidence indicates that extracellular adenosine triphosphate (eATP), as a major mediator of purinergic signaling, plays an important role in regulating the mobilization and homing of hematopoietic stem progenitor cells (HSPCs). In our previous work we demonstrated that eATP activates the P2X7 ion channel receptor in HSPCs and that its deficiency impairs stem cell trafficking. To learn more about the role of the P2X purinergic receptor family in hematopoiesis, we phenotyped murine and human HSPCs with respect to the seven P2X receptors and observed that, these cells also highly express P2X4 receptors, which shows ~50% sequence similarity to P2X7 subtypes, but that P2X4 cells are more sensitive to eATP and signal much more rapidly. Using the selective P2X4 receptor antagonist PSB12054 as well as P2X4-KO mice, we found that the P2X4 receptor, similar to P2X7 receptor, promotes trafficking of HSPCs in that its deficiency leads to impaired chemotaxis of HSPCs in response to a stromal-derived factor 1 (SDF-1) gradient, less effective pharmacological mobilization, and defective homing and engraftment of HSPCs after transplantation into myeloablated hosts. This correlated with a decrease in SDF-1 expression in the BM microenvironment. Overall, our results confirm the proposed cooperative dependence of both receptors in response to eATP signaling. In G-CSF-induced mobilization, a lack of one receptor is not compensated by the presence of the other one, which supports their mutual dependence in regulating HSPC trafficking.
- Published
- 2021
27. Innate immunity orchestrates the mobilization and homing of hematopoietic stem/progenitor cells by engaging purinergic signaling—an update
- Author
-
Arjun Thapa, Mariusz Z. Ratajczak, Kamila Bujko, Magda Kucia, Henning Ulrich, Mateusz Adamiak, Valentina Pensato, Janina Ratajczak, Ratajczak M.Z., Adamiak M., Bujko K., Thapa A., Pensato V., Kucia M., Ratajczak J., and Ulrich H.
- Subjects
0301 basic medicine ,Adenosine ,Review Article ,Biology ,Hematopoietic stem cell ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,Bone Marrow ,Cell Movement ,medicine ,Animals ,Humans ,Extracellular ATP ,Progenitor cell ,Molecular Biology ,Innate immunity ,Innate immune system ,Purinergic signaling ,ADENOSINA ,Cell Biology ,Stem cell mobilization and homing ,Purinergic signalling ,Hematopoietic Stem Cells ,Hematopoietic Stem Cell Mobilization ,Immunity, Innate ,Cell biology ,Transplantation ,Haematopoiesis ,030104 developmental biology ,medicine.anatomical_structure ,Bone marrow ,030217 neurology & neurosurgery ,Homeostasis ,Homing (hematopoietic) - Abstract
Bone marrow (BM) as an active hematopoietic organ is highly sensitive to changes in body microenvironments and responds to external physical stimuli from the surrounding environment. In particular, BM tissue responds to several cues related to infections, strenuous exercise, tissue/organ damage, circadian rhythms, and physical challenges such as irradiation. These multiple stimuli affect BM cells to a large degree through a coordinated response of the innate immunity network as an important guardian for maintaining homeostasis of the body. In this review, we will foc++us on the role of purinergic signaling and innate immunity in the trafficking of hematopoietic stem/progenitor cells (HSPCs) during their egression from the BM into peripheral blood (PB), as seen along pharmacological mobilization, and in the process of homing and subsequent engraftment into BM after hematopoietic transplantation. Innate immunity mediates these processes by engaging, in addition to certain peptide-based factors, other important non-peptide mediators, including bioactive phosphosphingolipids and extracellular nucleotides, as the main topic of this review. Elucidation of these mechanisms will allow development of more efficient stem cell mobilization protocols to harvest the required number of HSPCs for transplantation and to accelerate hematopoietic reconstitution in transplanted patients.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.